Modulation of Creutzfeldt‐Jakob disease prion propagation by the A224V mutation

Objective: Mutations in the gene encoding the prion protein (PrP) are responsible for approximately 10 to 15% of cases of prion disease in humans, including Creutzfeldt-Jakob disease (CJD). Here, we report on the discovery of a previously unreported C-terminal PrP mutation (A224V) in a CJD patient exhibiting a disease similar to the rare VV1 subtype of sporadic (s) CJD and investigate the role of this mutation in prion replication and transmission. Methods: We generated transgenic (Tg) mice expressing human PrP with the V129 polymorphism and A224V mutation, denoted Tg(HuPrP, V129, A224V) mice, and inoculated them with different subtypes of sCJD prions. Results: Transmission of sCJD VV2 or MV2 prions was accelerated in Tg(HuPrP, V129, A224V) mice, compared to Tg(HuPrP, V129) mice, with incubation periods of similar to 110 and similar to 210 days, respectively. In contrast, sCJD MM1 prions resulted in longer incubation periods in Tg(HuPrP, V129, A224V) mice, compared to Tg(HuPrP, V129) mice (similar to 320 vs. similar to 210 days). Prion strain fidelity was maintained in Tg(HuPrP, V129, A224V) mice inoculated with sCJD VV2 or MM1 prions, despite the altered replication kinetics. Interpretation: Our results suggest that A224V is a risk factor for prion disease and modulates the transmission behavior of CJD prions in a strain-specific manner, arguing that residues near the C-terminus of PrP are important for controlling the kinetics of prion replication.